Discovering the anticancer potential of non-oncology drugs by systematic viability profiling

Steven M. Corsello(Broad Institute), Rohith T. Nagari(Broad Institute), Ryan D. Spangler(Broad Institute), Jordan Rossen(Broad Institute), Mustafa Kocak(Broad Institute), Jordan Bryan(Broad Institute), Ranad Humeidi(Broad Institute), D. D. Peck(Broad Institute), Xiaoyun Wu(Broad Institute), Andrew Tang(Broad Institute), Vickie M. Wang(Broad Institute), Samantha Bender(Broad Institute), Evan Lemire(Broad Institute), Rajiv Narayan(Broad Institute), Philip Montgomery(Broad Institute), Uri Ben‐David(Broad Institute), Colin W. Garvie(Broad Institute), Yejia Chen(Broad Institute), Matthew G. Rees(Broad Institute), Nicholas Lyons(Broad Institute), James M. McFarland(Broad Institute), Bang Wong(Broad Institute), Li Wang(Broad Institute), Nancy Dumont(Broad Institute), Patrick J. O’Hearn(Broad Institute), Eric Stefan(Broad Institute), John G. Doench(Broad Institute), Caitlin Harrington(Broad Institute), Heidi Greulich(Broad Institute), Matthew Meyerson(Broad Institute), Francisca Vázquez(Broad Institute), Aravind Subramanian(Broad Institute), Jennifer A. Roth(Broad Institute), Joshua A. Bittker(Broad Institute), Jesse S. Boehm(Broad Institute), Christopher C. Mader(Broad Institute), Aviad Tsherniak(Broad Institute), Todd R. Golub(Broad Institute)
Nature Cancer
January 20, 2020
Cited by 875Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis